RxDoctor Payments Data

Candace Spann, MD

Dermatology · Las Vegas, NVNPI 1700964780

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Lilly USA, LLC at 48.8% of the total. Reporting peaked in 2024 at $9,499 and has fallen 90.7% since, to $888 in 2025.

$18,113in general payments, 2019–2025

Across 361 payments — averaging $50.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$9K
  • EPI Health, LLC$3K
  • AbbVie$2K
  • Pfizer$498
  • UCB, Inc.$469
  • Johnson & Johnson$421
  • plus $4K from 27 others

What the payments were for

  • Consulting fees$2,40013%
  • Speaking & faculty fees$8,25046%
  • Food & beverage$7,17040%
  • Education$2932%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,113 in reported general payments places this provider in the 85th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Medicare billing

Part B allowed, 2024
$398,506
Medicare patients
382
Services billed
1,400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab24$273,614
Dupixent PenDupilumab14$52,384
Acitretin12$7,009
CiclopiroxCiclopirox Olamine61$1,394
Clobetasol Propionate32$881
Triamcinolone Acetonide36$739
ValacyclovirValacyclovir Hcl33$629
Mupirocin34$242
Ketoconazole22$226
Fluconazole21$141
Vitamin D2Ergocalciferol (Vitamin D2)18$131
Hydrocortisone11$130
Dutasteride25$125
Doxycycline Hyclate15$117
Hydroxyzine Hcl14$91

Paid to pharmacies, not to this prescriber.

Other dermatology in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →